The Latin America, Middle East and Africa Heparin Market would witness market growth of 7.5% CAGR during the forecast period (2021-2027).
The increasing demand for heparin among patients suffering from the chronic blood-related disorder. It is boosting the demand for heparin and expected to have an excellent impact on the market growth. According to the Centers for Disease Control and Prevention, the increasing incidence of chronic blood-related diseases such as heart disease has killed about 365,914 people in 2017. The awareness about the benefits of heparin has been increased. The awareness about the treatment and management of heart diseases is likely to improve the prospects of the heparin market in the forecast period.
Moreover, biopharmaceutical companies are actively working to develop innovative medicines to improve the therapeutic potential of heparin. The market is also driven by the various advancements for carbohydrate synthesis and building block preparation. Furthermore, government funding with an aim to improve healthcare facilities is also increasing. The extensive research and development (R&D) activities to develop heparin with ultra-low molecular weight are also creating positive growth opportunities for the market.
The health care infrastructure is not very advanced in Sub-Saharan Africa. But, the incidences of chronic heart disease are high in this region. The WHO estimated that more than 17.7 million people died from CVDs in 2015 that represents approximately 31% of all global deaths. People who are suffering from cardiovascular disease are at risk of hypertension, diabetes, hyperlipidemia. Thus, it requires early detection and management to prevent the number of deaths occurring due to CVD. The burden of cardiomyopathies, cerebrovascular disease, and rheumatic heart disease are still very predominant in many regions of Africa. Therefore, the demand for heparin for the treatment of cardiovascular disease is increasing. It is a major factor that is expected to contribute to the growth of the market during the forecast period. Heparin is used in surgery as it reduces the risk of a blood clots in the arteries, veins, or lungs. Therefore, the demand for heparin has been increased over the past few years.
The Brazil market dominated the LAMEA Inpatient Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $204.4 million by 2027. The Argentina market would witness a CAGR of 9% during (2021 - 2027). Additionally, The UAE market is expected to witness a CAGR of 7% during (2021 - 2027).
Based on Type, the market is segmented into Low Molecular Weight Heparin, Unfractionated Heparin and Ultra-low Molecular Weight Heparin. Based on Application, the market is segmented into Atrial Fibrillation, Coronary Artery Disease, Venous Thromboembolism, Renal Impairment and Other Applications. Based on Route of Administration, the market is segmented into Subcutaneous and Intravenous. Based on End Use, the market is segmented into Outpatient and Inpatient. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Heparin Market is Predict to reach $10 Billion by 2027, at a CAGR of 6.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Pfizer, Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, and Viatris, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Usability
- Average-type
- Premium-type
- Low-type
By Product
- Surgical Gowns
- Patient Gowns
- Non-surgical Gowns
By Risk Type
- Moderate risk Gowns
- High risk Gowns
- Low risk Gowns
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Baxter International, Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Pfizer, Inc.
- Sanofi S.A.
- Teva Pharmaceuticals Industries Ltd.
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
- Dr. Reddy’s Laboratories Ltd.
- LEO Pharma A/S
- Viatris, Inc.
TABLE 1 LAMEA Heparin Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Heparin Market, 2021 - 2027, USD Million
TABLE 3 LAMEA Heparin Market by Type, 2017 - 2020, USD Million
TABLE 4 LAMEA Heparin Market by Type, 2021 - 2027, USD Million
TABLE 5 LAMEA Low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 6 LAMEA Low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 7 LAMEA Unfractionated Heparin Market by Country, 2017 - 2020, USD Million
TABLE 8 LAMEA Unfractionated Heparin Market by Country, 2021 - 2027, USD Million
TABLE 9 LAMEA Ultra-low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 10 LAMEA Ultra-low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 11 LAMEA Heparin Market by Application, 2017 - 2020, USD Million
TABLE 12 LAMEA Heparin Market by Application, 2021 - 2027, USD Million
TABLE 13 LAMEA Atrial Fibrillation Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA Atrial Fibrillation Market by Country, 2021 - 2027, USD Million
TABLE 15 LAMEA Coronary Artery Disease Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Coronary Artery Disease Market by Country, 2021 - 2027, USD Million
TABLE 17 LAMEA Venous Thromboembolism Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Venous Thromboembolism Market by Country, 2021 - 2027, USD Million
TABLE 19 LAMEA Renal Impairment Market by Country, 2017 - 2020, USD Million
TABLE 20 LAMEA Renal Impairment Market by Country, 2021 - 2027, USD Million
TABLE 21 LAMEA Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 22 LAMEA Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 23 LAMEA Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 24 LAMEA Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 25 LAMEA Subcutaneous Market by Region, 2017 - 2020, USD Million
TABLE 26 LAMEA Subcutaneous Market by Region, 2021 - 2027, USD Million
TABLE 27 LAMEA Intravenous Market by Region, 2017 - 2020, USD Million
TABLE 28 LAMEA Intravenous Market by Region, 2021 - 2027, USD Million
TABLE 29 LAMEA Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 30 LAMEA Heparin Market by End USe, 2021 - 2027, USD Million
TABLE 31 LAMEA Outpatient Market by Country, 2017 - 2020, USD Million
TABLE 32 LAMEA Outpatient Market by Country, 2021 - 2027, USD Million
TABLE 33 LAMEA Inpatient Market by Country, 2017 - 2020, USD Million
TABLE 34 LAMEA Inpatient Market by Country, 2021 - 2027, USD Million
TABLE 35 LAMEA Heparin Market by Region, 2017 - 2020, USD Million
TABLE 36 LAMEA Heparin Market by Region, 2021 - 2027, USD Million
TABLE 37 Brazil Heparin Market, 2017 - 2020, USD Million
TABLE 38 Brazil Heparin Market, 2021 - 2027, USD Million
TABLE 39 Brazil Heparin Market by Type, 2017 - 2020, USD Million
TABLE 40 Brazil Heparin Market by Type, 2021 - 2027, USD Million
TABLE 41 Brazil Heparin Market by Application, 2017 - 2020, USD Million
TABLE 42 Brazil Heparin Market by Application, 2021 - 2027, USD Million
TABLE 43 Brazil Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 44 Brazil Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 45 Brazil Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 46 Brazil Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 47 Argentina Heparin Market, 2017 - 2020, USD Million
TABLE 48 Argentina Heparin Market, 2021 - 2027, USD Million
TABLE 49 Argentina Heparin Market by Type, 2017 - 2020, USD Million
TABLE 50 Argentina Heparin Market by Type, 2021 - 2027, USD Million
TABLE 51 Argentina Heparin Market by Application, 2017 - 2020, USD Million
TABLE 52 Argentina Heparin Market by Application, 2021 - 2027, USD Million
TABLE 53 Argentina Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 54 Argentina Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 55 Argentina Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 56 Argentina Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 57 UAE Heparin Market, 2017 - 2020, USD Million
TABLE 58 UAE Heparin Market, 2021 - 2027, USD Million
TABLE 59 UAE Heparin Market by Type, 2017 - 2020, USD Million
TABLE 60 UAE Heparin Market by Type, 2021 - 2027, USD Million
TABLE 61 UAE Heparin Market by Application, 2017 - 2020, USD Million
TABLE 62 UAE Heparin Market by Application, 2021 - 2027, USD Million
TABLE 63 UAE Unfractionated Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 64 UAE Unfractionated Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 65 UAE Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 66 UAE Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 67 Saudi Arabia Heparin Market, 2017 - 2020, USD Million
TABLE 68 Saudi Arabia Heparin Market, 2021 - 2027, USD Million
TABLE 69 Saudi Arabia Heparin Market by Type, 2017 - 2020, USD Million
TABLE 70 Saudi Arabia Heparin Market by Type, 2021 - 2027, USD Million
TABLE 71 Saudi Arabia Heparin Market by Application, 2017 - 2020, USD Million
TABLE 72 Saudi Arabia Heparin Market by Application, 2021 - 2027, USD Million
TABLE 73 Saudi Arabia Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 74 Saudi Arabia Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 75 Saudi Arabia Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 76 Saudi Arabia Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 77 South Africa Heparin Market, 2017 - 2020, USD Million
TABLE 78 South Africa Heparin Market, 2021 - 2027, USD Million
TABLE 79 South Africa Heparin Market by Type, 2017 - 2020, USD Million
TABLE 80 South Africa Heparin Market by Type, 2021 - 2027, USD Million
TABLE 81 South Africa Heparin Market by Application, 2017 - 2020, USD Million
TABLE 82 South Africa Heparin Market by Application, 2021 - 2027, USD Million
TABLE 83 South Africa Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 84 South Africa Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 85 South Africa Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 86 South Africa Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 87 Nigeria Heparin Market, 2017 - 2020, USD Million
TABLE 88 Nigeria Heparin Market, 2021 - 2027, USD Million
TABLE 89 Nigeria Heparin Market by Type, 2017 - 2020, USD Million
TABLE 90 Nigeria Heparin Market by Type, 2021 - 2027, USD Million
TABLE 91 Nigeria Heparin Market by Application, 2017 - 2020, USD Million
TABLE 92 Nigeria Heparin Market by Application, 2021 - 2027, USD Million
TABLE 93 Nigeria Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 94 Nigeria Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 95 Nigeria Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 96 Nigeria Ultra-Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 97 Rest of LAMEA Heparin Market, 2017 - 2020, USD Million
TABLE 98 Rest of LAMEA Heparin Market, 2021 - 2027, USD Million
TABLE 99 Rest of LAMEA Heparin Market by Type, 2017 - 2020, USD Million
TABLE 100 Rest of LAMEA Heparin Market by Type, 2021 - 2027, USD Million
TABLE 101 Rest of LAMEA Heparin Market by Application, 2017 - 2020, USD Million
TABLE 102 Rest of LAMEA Heparin Market by Application, 2021 - 2027, USD Million
TABLE 103 Rest of LAMEA Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 104 Rest of LAMEA Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 105 Rest of LAMEA Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 106 Rest of LAMEA Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 107 Key Information – Baxter International, Inc.
TABLE 108 key Information – B. Braun Melsungen AG
TABLE 109 key information – Fresenius SE & Co. KGaA
TABLE 110 Key Information – Pfizer, Inc.
TABLE 111 Key Information – Sanofi S.A.
TABLE 112 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 113 key information – Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
TABLE 114 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 115 key information – LEO Pharma A/S
TABLE 116 key information – Viatris, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Fresenius SE & Co. KGaA